Stockreport

Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes [Financial Post (Toront...

Achieve Life Sciences, Inc. - Common Shares  (ACHV) 
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achievelifesciences.com
PDF The open-label trial is being conducted at 29 sites in the United States and will provide required longer-term safety data for the cytisinicline NDA submission, which i [Read more]